These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37604227)

  • 21. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.
    Marsche G; Frank S; Raynes JG; Kozarsky KF; Sattler W; Malle E
    Biochem J; 2007 Feb; 402(1):117-24. PubMed ID: 17034364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Amyloid A (SAA) Proteins.
    Sack GH
    Subcell Biochem; 2020; 94():421-436. PubMed ID: 32189310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake.
    Cai L; de Beer MC; de Beer FC; van der Westhuyzen DR
    J Biol Chem; 2005 Jan; 280(4):2954-61. PubMed ID: 15561721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
    Kawahara E; Shiroo M; Nakanishi I; Migita S
    Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum amyloid A sequesters diverse phospholipids and their hydrolytic products, hampering fibril formation and proteolysis in a lipid-dependent manner.
    Jayaraman S; Gantz DL; Haupt C; Fändrich M; Gursky O
    Chem Commun (Camb); 2018 Apr; 54(28):3532-3535. PubMed ID: 29565436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amyloid A1: Structure, function and gene polymorphism.
    Sun L; Ye RD
    Gene; 2016 May; 583(1):48-57. PubMed ID: 26945629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.
    Tanaka M; Kawakami T; Okino N; Sasaki K; Nakanishi K; Takase H; Yamada T; Mukai T
    Arch Biochem Biophys; 2018 Feb; 639():9-15. PubMed ID: 29288051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.
    Jayaraman S; Haupt C; Gursky O
    J Lipid Res; 2015 Aug; 56(8):1531-42. PubMed ID: 26022803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture.
    Hoffman JS; Benditt EP
    J Biol Chem; 1982 Sep; 257(17):10518-22. PubMed ID: 6809750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL.
    Pruzanski W; Stefanski E; de Beer FC; de Beer MC; Vadas P; Ravandi A; Kuksis A
    J Lipid Res; 1998 Nov; 39(11):2150-60. PubMed ID: 9799801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.
    Hoffman JS; Benditt EP
    J Biol Chem; 1982 Sep; 257(17):10510-7. PubMed ID: 7107614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of serum amyloid A on high density lipoprotein composition and levels.
    de Beer MC; Webb NR; Wroblewski JM; Noffsinger VP; Rateri DL; Ji A; van der Westhuyzen DR; de Beer FC
    J Lipid Res; 2010 Nov; 51(11):3117-25. PubMed ID: 20667817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
    Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.
    Elimova E; Kisilevsky R; Szarek WA; Ancsin JB
    FASEB J; 2004 Nov; 18(14):1749-51. PubMed ID: 15345688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential affinity of serum amyloid A1 isotypes for high-density lipoprotein.
    Yamada T; Sato J; Okuda Y
    Amyloid; 2009 Dec; 16(4):196-200. PubMed ID: 19922330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models for reactive amyloidosis.
    Gruys E; Snel FW
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):599-611. PubMed ID: 7954864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein.
    Santoso A; Kaniawati M; Bakri S; Yusuf I
    Int J Angiol; 2013 Mar; 22(1):49-54. PubMed ID: 24436584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.
    Kim MH; de Beer MC; Wroblewski JM; Charnigo RJ; Ji A; Webb NR; de Beer FC; van der Westhuyzen DR
    J Lipid Res; 2016 Jun; 57(6):969-79. PubMed ID: 27018443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.
    Ancsin JB; Kisilevsky R
    J Biol Chem; 1999 Mar; 274(11):7172-81. PubMed ID: 10066777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.